The Procter & Gamble Company
PG
$170.56
$0.140.08%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | 21.44B | 21.87B | 20.55B | 20.07B | 20.77B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 21.44B | 21.87B | 20.55B | 20.07B | 20.77B |
Cost of Revenue | 10.14B | 10.50B | 10.45B | 10.40B | 10.90B |
Gross Profit | 11.30B | 11.37B | 10.10B | 9.66B | 9.88B |
SG&A Expenses | 5.42B | 5.61B | 5.28B | 5.33B | 5.00B |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 15.56B | 16.11B | 15.73B | 15.73B | 15.90B |
Operating Income | 5.88B | 5.77B | 4.82B | 4.33B | 4.87B |
Income Before Tax | 4.50B | 5.80B | 4.23B | 4.29B | 4.84B |
Income Tax Expenses | 1.00B | 1.25B | 841.00M | 864.00M | 876.00M |
Earnings from Continuing Operations | 3.49B | 4.56B | 3.39B | 3.42B | 3.96B |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -25.00M | -35.00M | -8.00M | -27.00M | -26.00M |
Net Income | 3.47B | 4.52B | 3.38B | 3.40B | 3.93B |
EBIT | 5.88B | 5.77B | 4.82B | 4.33B | 4.87B |
EBITDA | 6.60B | 6.47B | 5.53B | 5.03B | 5.53B |
EPS Basic | 1.44 | 1.89 | 1.37 | 1.41 | 1.63 |
Normalized Basic EPS | 1.54 | 1.52 | 1.18 | 1.12 | 1.27 |
EPS Diluted | 1.41 | 1.83 | 1.37 | 1.37 | 1.59 |
Normalized Diluted EPS | 1.47 | 1.45 | 1.15 | 1.07 | 1.21 |
Average Basic Shares Outstanding | 2.36B | 2.36B | 2.42B | 2.36B | 2.37B |
Average Diluted Shares Outstanding | 2.47B | 2.48B | 2.48B | 2.47B | 2.48B |
Dividend Per Share | 0.94 | 0.94 | 0.94 | 0.91 | 0.91 |
Payout Ratio | 65.97% | 50.65% | -- | 65.47% | 56.73% |